SCHEMBL26633717

SCHEMBL26633717

COc1ccc(CNC(=O)NC2CC3(C2)CN(C(=O)Cc2ccccc2C(F)(F)F)C3)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ POLB P06746 1/20 0.43
▸ GAA P10253 2/20 0.43
▸ MCHR1 Q99705 2/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CCR3 P51677 1/20 0.39
▸ EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011148 0.89 RAB9A (0.54) RAB9ANPC1SMN1; SMN2POLBGAA
SCHEMBL26764084 0.88 RAB9A (0.50) RAB9ANPC1SMN1; SMN2GAAMCHR1
SCHEMBL30306658 0.88 RAB9A (0.50) RAB9ANPC1SMN1; SMN2GAAMCHR1
SCHEMBL26764090 0.87 NPC1 (0.51) RAB9ANPC1SMN1; SMN2GAAMCHR1
SCHEMBL26764091 0.87 CCR3 (0.52) RAB9ANPC1SMN1; SMN2MCHR1HRH3
SCHEMBL30306642 0.87 NPC1 (0.51) RAB9ANPC1SMN1; SMN2GAAMCHR1
SCHEMBL30306654 0.87 CCR3 (0.52) RAB9ANPC1SMN1; SMN2MCHR1HRH3
SCHEMBL30306671 0.86 NPC1 (0.50) RAB9ANPC1SMN1; SMN2MCHR1HRH3
SCHEMBL26764086 0.86 NPC1 (0.50) RAB9ANPC1SMN1; SMN2MCHR1HRH3
SCHEMBL26633832 0.80 SMN1; SMN2 (0.48) RAB9ANPC1SMN1; SMN2GAAMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
EP-4146640-A2 NAMPT MODULATORS Cytokinetics, Inc. (US) 2023-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT RAB9A 814/4885NPC1 128/4885SMN1; SMN2 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback